Anti-CD20 monoclonal antibodies (mAbs), which act as B-cell–depleting therapies, are important treatments for a range of pediatric kidney diseases. Read this Educ Review of infection prophylaxis following mAbs in childhood kidney diseases. Open Access
link.springer.com/article/10.1...
